BNP Paribas Financial Markets raised its position in shares of Amdocs Limited (NASDAQ:DOX – Free Report) by 85.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 201,982 shares of the technology company’s stock after purchasing an additional 93,036 shares during the period. BNP Paribas Financial Markets’ holdings in Amdocs were worth $16,262,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. WealthCollab LLC raised its position in shares of Amdocs by 94.5% during the 3rd quarter. WealthCollab LLC now owns 356 shares of the technology company’s stock worth $29,000 after buying an additional 173 shares in the last quarter. Atlantic Union Bankshares Corp bought a new stake in shares of Amdocs during the 3rd quarter worth about $37,000. BOK Financial Private Wealth Inc. bought a new stake in shares of Amdocs during the 4th quarter worth about $37,000. Abich Financial Wealth Management LLC bought a new stake in shares of Amdocs during the 3rd quarter worth about $39,000. Finally, Advisory Services Network LLC bought a new stake in shares of Amdocs during the 3rd quarter worth about $42,000. 92.02% of the stock is owned by institutional investors and hedge funds.
Amdocs News Summary
Here are the key news stories impacting Amdocs this week:
- Positive Sentiment: Zacks Research lifted its FY2026 EPS estimate to $6.60 from $6.56, suggesting slightly better near-term earnings potential. Amdocs estimate update
- Positive Sentiment: The firm also raised FY2027 EPS to $7.12 from $7.04 and FY2028 EPS to $7.69 from $7.55, indicating improving longer-term profit expectations. Amdocs estimate update
- Positive Sentiment: Quarterly estimates for Q4 2026, Q3 2027, Q4 2027, Q1 2028 and Q2 2028 were all nudged higher, which can reinforce optimism about Amdocs’ earnings trajectory. Amdocs estimate update
- Neutral Sentiment: Zacks kept its full-year consensus context broadly unchanged, with current-year EPS still expected at $6.54, so the revisions were incremental rather than dramatic. Amdocs estimate update
- Negative Sentiment: Near-term outlook was slightly softer for Q3 2026, with EPS cut to $1.67 from $1.68, and Q2 2027 was reduced to $1.70 from $1.73, which may have weighed on sentiment. Amdocs estimate update
Wall Street Analyst Weigh In
Read Our Latest Research Report on DOX
Amdocs Stock Down 1.2%
NASDAQ DOX opened at $60.09 on Friday. The company has a debt-to-equity ratio of 0.23, a current ratio of 0.98 and a quick ratio of 0.98. The company’s 50 day simple moving average is $63.97 and its 200 day simple moving average is $71.39. Amdocs Limited has a 12 month low of $59.40 and a 12 month high of $95.41. The company has a market capitalization of $6.49 billion, a P/E ratio of 12.02, a PEG ratio of 1.04 and a beta of 0.38.
Amdocs (NASDAQ:DOX – Get Free Report) last released its earnings results on Thursday, May 14th. The technology company reported $1.78 EPS for the quarter, topping analysts’ consensus estimates of $1.77 by $0.01. Amdocs had a net margin of 11.81% and a return on equity of 19.77%. The business had revenue of $1.17 billion for the quarter, compared to the consensus estimate of $1.17 billion. During the same period in the previous year, the firm earned $1.78 EPS. The business’s revenue for the quarter was up 3.9% on a year-over-year basis. Equities research analysts expect that Amdocs Limited will post 6.56 earnings per share for the current fiscal year.
Amdocs Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be given a $0.569 dividend. This represents a $2.28 annualized dividend and a dividend yield of 3.8%. The ex-dividend date of this dividend is Tuesday, June 30th. Amdocs’s dividend payout ratio (DPR) is 45.60%.
About Amdocs
Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.
Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.
Recommended Stories
- Five stocks we like better than Amdocs
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX – Free Report).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
